Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali T Taher

Showing results (1-10 of 297) with videos related to

Pageof 30
Sort By:
Nature Medicine|May 18, 2026
When cure exists but access does notAli T Taher
American Journal of Hematology|August 27, 2025
Innovation Alone Is Not Enough: The Urgent Need for Equitable Access in Thalassemia CareAli T Taher
Hematology/Oncology Clinics of North America|February 21, 2018
ThalassemiaAli T Taher
British Journal of Haematology|March 13, 2016
Clinical utility of serum ferritin thresholds for guiding iron chelation therapy when magnetic resonance imaging is unavailable in patients with non-transfusion-dependent thalassaemias - response to Ang et alAli T Taher
Injury|July 20, 2010
How long should we delay hip fracture surgery for elderly patients on clopidogrel?Rachid Haidar, Ali T Taher
Hematology. American Society of Hematology. Education Program|December 7, 2024
Luspatercept: a treatment for ineffective erythropoiesis in thalassemiaKhaled M Musallam, Ali T Taher
American Journal of Hematology|October 21, 2020
A land in agony: COVID-19, economic collapse, political corruption, and a deadly blastAntoine N Saliba, Ali T Taher
American Journal of Hematology|June 6, 2015
Comment on "deferiprone versus deferoxamine in thalassemia intermedia: results from a 5-year long-term Italian multicenter randomized clinical trial"Antoine N Saliba, Ali T Taher
Medical Hypotheses|June 11, 2021
Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia?Georges El Hasbani, Ali T Taher
Hemoglobin|September 14, 2011
Iron chelation therapy for transfusional iron overload: a swift evolutionKhaled M Musallam, Ali T Taher
Pageof 30

Showing results (1-10 of 297) with videos related to

Sort By:
Pageof 30
Nature Medicine|May 18, 2026
When cure exists but access does notAli T Taher
American Journal of Hematology|August 27, 2025
Innovation Alone Is Not Enough: The Urgent Need for Equitable Access in Thalassemia CareAli T Taher
Hematology/Oncology Clinics of North America|February 21, 2018
ThalassemiaAli T Taher
British Journal of Haematology|March 13, 2016
Clinical utility of serum ferritin thresholds for guiding iron chelation therapy when magnetic resonance imaging is unavailable in patients with non-transfusion-dependent thalassaemias - response to Ang et alAli T Taher
Injury|July 20, 2010
How long should we delay hip fracture surgery for elderly patients on clopidogrel?Rachid Haidar, Ali T Taher
Hematology. American Society of Hematology. Education Program|December 7, 2024
Luspatercept: a treatment for ineffective erythropoiesis in thalassemiaKhaled M Musallam, Ali T Taher
American Journal of Hematology|October 21, 2020
A land in agony: COVID-19, economic collapse, political corruption, and a deadly blastAntoine N Saliba, Ali T Taher
American Journal of Hematology|June 6, 2015
Comment on "deferiprone versus deferoxamine in thalassemia intermedia: results from a 5-year long-term Italian multicenter randomized clinical trial"Antoine N Saliba, Ali T Taher
Medical Hypotheses|June 11, 2021
Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia?Georges El Hasbani, Ali T Taher
Hemoglobin|September 14, 2011
Iron chelation therapy for transfusional iron overload: a swift evolutionKhaled M Musallam, Ali T Taher
Pageof 30